Ethosomes for the delivery of anti-HSV-1 molecules: Preparation, characterization and in vitro activity

Pharmazie

Volumn 65, Issue 10, 2010, Pages 743-749

  Cortesi, Rita ^a   Ravani, L ^a   Zaid, A N ^a,b   Menegatti, E ^a   Romagnoli, R ^a   Drechsler, M ^c   Esposito, E ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b AN NAJAH NATIONAL UNIVERSITY   (Palestine)

^c UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ETHOSOME; N1 BETA DEXTRO RIBOFURANOSYLPYRAZOLE[3,4 D]PYRIDAZIN 7 (6P CHLORINE PHENYL)ONE; NUCLEOSIDE DERIVATIVE; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; FREEZE DRYING; HERPES SIMPLEX VIRUS 1; IN VITRO STUDY; NONHUMAN; VERO CELL;

ACYCLOVIR; ANTIVIRAL AGENTS; CELL SURVIVAL; DIFFUSION; DRUG COMPOUNDING; ELECTROCHEMISTRY; FREEZE DRYING; HERPESVIRUS 1, HUMAN; MICROSCOPY, ELECTRON, SCANNING; MICROSOMES; PARTICLE SIZE; PHARMACEUTICAL VEHICLES; PLAQUE ASSAY; TETRAZOLIUM SALTS; THIAZOLES;

EID: 78349280726     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0106     Document Type: Article

References (27)

1. Abla N, Naik A, Guy RH, Kalia YN (2006) Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery. Pharm Res 23: 1842-1849. (Pubitemid 44200548)
2. Bando H, Sahashi M, Mohri S, Yamashita F, Takakura Y, Hashida M (1996) In vivo skin penetration enhancement of acyclovir by theoretical design of prodrug-enhancer combination. Int J Pharm 145: 103-113.
3. Baraldi PG, Manfredini S, Romagnoli R, Stevanato L, Zaid AN, Manservigi R (1998) Synthesis and anti-HSV-1 activity of 6 substituted pyrazole[3,4-d] pyridazin-7-one nucleosides. Nucleosides, Nucleotides and Nucleic Acids 17: 2165-2173. (Pubitemid 28553124)
4. Blum MR, Liao SHT, Miranad PD (1982) Overview of acyclovir pharmacokinetic disposition in adults and children. Am J Med 73(suppl): 186-192. (Pubitemid 12067782)
5. Cortesi R, Esposito E, Nastruzzi C (2000) Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes. Antisense Nucl Acid Drug Develop 10: 205-215. (Pubitemid 30487621)
6. Esposito E, Menegatti E, Cortesi R (2004) Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulatory study. J Cosm Sci 55: 253-264. (Pubitemid 39091806)
7. Freeman DJ, Sheth NV, Spruance SL (1986) Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob Agents Chemother 29: 730-732.
8. Godin B, Touitou E (2003) Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 20: 63-102. (Pubitemid 36929628)
9. Hill EL, Ellis MN, Nguyen-Dinh P (1991) Antiviral and antiparasitic susceptibility testing. In: American Society for Microbiology (eds.) Manual of Clinical Microbiology, Washington DC, 1184-1191.
10. Horwitz E, Pisanty S, Czerninski R, Helser M, Eliav E, Touitou E (1999) A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88: 700-705.
11. Jiang M, Quresh SA, Midha KK, Skelly JP (1998) In Vitro evaluation of percutaneous absorption of an acyclovir product using intact and tape-stripped human skin. J Pharm Pharmaceut Sci 1: 102-107.
12. Klimowicz A, Farfal S, Bielecka-Grzela S (2007) Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid. J Clin Pharm Therap 32: 143-148. (Pubitemid 46449702)
13. Ita KB, Du Preez J, Lane ME, Hadgraft J, Du Plessis J (2007) Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants. J Pharm Pharmacol 59: 1215-1222. (Pubitemid 47359900)
14. Jain S, Tiwary AK, Sapra B, Jain NK (2007) Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 8 (4): Article 111.
15. Mayer LD, Hope MJ, Cullis PR (1986) Vesicles of variable size produced by a rapid extrusion procedure. Biochim Biophys Acta 858: 161-168.
16. Modiano P, Salloum E, Gillet-Terver MN, Barbaud A, Georges JC, Thouvenot D, Schmutz JL, Weber M (1995) Acyclovir-resistant chronic cutaneous herpes simplex in Wiskott-Aldrich syndrom. Brit J Dermatol 133: 475-478.
17. Nastruzzi C, Esposito E, Pastesini C, Gambari R, Menegatti E (1993) Comparative study on the release kinetics of methyl nicotinate from topic formulations. Int J Pharm 90: 43-50. (Pubitemid 23063430)
18. Pope LE, Marcelletti JF, Katz LR, Lin JY, Katz DH, Parish ML, Spear PG (1998) The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process. Antiviral Res 40: 85-94.
19. Reichman RC, Badger G.J, Mertz GJ, Corey L, Richman DD, Connor JD, Redfield D, Savoia MC, Oxman MN, Bryson Y (1984) Treatment of recurrent genital herpes simplex infections with oral acyclovir: A controlled trial. J Am Med Assoc 251: 2103-2107. (Pubitemid 14133504)
20. Richards DM, Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS (1983) Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 26: 378-438.
21. Shah PV, Elkins JS, Hanus J, Noorizadeh C, Skelly JP (1991) In vitro release of hydrocortisone from topical preparations and automated procedure. Pharm Res 8: 55-59.
22. Shah PV, Elkins JS, Williams RL (1993) In vitro drug release measurements for topical glucocorticid creams. Pharmacopeial Forum 19: 5048-5060.
23. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65: 403-418. (Pubitemid 30122942)
24. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F (2001) Intracellular delivery mediated by an ethosomal carrier. Biomaterials 22: 3053-3059. (Pubitemid 32768713)
25. Touitou E (2002) Drug delivery across the skin. Exp Opin Biol Ther 2: 723-733.
26. Touitou E, Godin B (2007) Dermal drug delivery with ethosomes: therapeutic potential. Therapy 4: 465-472. (Pubitemid 47083031)
27. Walro DG, Rosenthal KS (1997) The antiviral xanthate compound D609 inhibits herpes simplex virus type 1 replication and protein phosphorylation. Antiviral Res 36: 63-72.